Webinar series live dates: Tuesday 6/Tuesday 13/Tuesday 20 October 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Join us for a series of roundtables to explore key considerations of biomarker, oligonucleotide and cell and gene therapy bioanalytical strategies
Webinar live date: Thursday 24th September 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. This webinar describes the analysis and implementation of singlet analysis in ligand binding assays (LBA) for pharmacokinetic and toxicokinetic (PK/TK) analysis of antibody therapeutics.
Tuesday 29 September 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Bioanalysis Zone is delighted to offer its members unique access to this panel discussion focusing on drug development and discovery post COVID-19, new developments in instrumentation and the practical implications of COVID-19 on the bioanalytical laboratory.
Webinar available on demand. This webinar will discuss the applications of ELISpot assays to detect cellular immune responses to specific antigens associated with viral vector-based gene therapies.
Webinar available on demand. Register for our exclusive Coffee Chat focusing on the quantification of biologics by LC–MS. This informal discussion centers around the use of bioanalytical strategies to support the development of bringing new biologics to market.
Webinar available on demand. Bioanalysis Zone is delighted to offer its members unique access to this panel discussion. The panel discussion focuses on new methods, the new age of biomarkers and current trends in non-standard bioanalytical techniques.
Webinar available on demand. This webinar will discuss how multi-parameter flow cytometry can be used to confidently detect, characterizeand quantitate rare-cell populations for clinical development applications.
Read expert answers to audience submitted questions during the recent panel discussion – COVID-19 and patient-centric sampling: how to fight a pandemic.
Webinar available on demand. Join us for an in-depth bioanalytical and clinical exploration, including case studies, of microsampling technology and its significance in supporting patient-centric healthcare initiatives.
Webinar available on demand. In this webinar, we will investigate ligand binding assays (LBAs) and LC–MS/MS generic PK methods for the quantification of therapeutic monoclonal antibodies in pre-clinical species.
Panel discussion available on demand. In this free panel discussion, our experts will provide insights into their own research and involvement with biomarker discovery including the challenges they have had to overcome, key trends they have seen and their future outlook on the development of this field.
In a new multicenter study, scientists demonstrate that a high-speed COVID-19 test has 94 per cent sensitivity and 100 per cent specificity. The test can be performed at a patient’s bedside and is currently being used successfully across eight London Hospitals.
Researchers from the University of Leeds (UK) have described a new biosensing platform for detecting biomarkers that makes use of ‘DNA origami’ – folding of DNA molecules into specific nanostructures – and nanopores to enable individual biomarker detection.
In this instalment of Robert MacNeill’s column, he explores the giddy realm of chromatographic bioanalysis and the less well-known phenomena that can affect band migration through a column.
In this feature, we peek behind the paper with Jing Yu and Amanda Hays (PRA Health Sciences, KS, USA) to gain insights into the key challenges of post sample collection whole blood stability. They explain the advantages of the lyse freeze method and how their approach, which has been demonstrated on Tregs, could be implemented in clinical trials that monitor other cellular markers.